research reports and media, page-3521

Kiwinvestor - I tend to agree...

Look, ideally we would have our Founder Led Chief as Chairman and we would have a super duper separate CEO in charge of operations and the business, to lead us to the next step; namely, greatness.


But we don't have this in place currently. The next best thing is to diligently and progressively tick off the coming important milestones...examples include:

• DSMB Safety Reports (three to come I believe)
• 008 Program : 6 and 12 Month
• 002 Phase 1 - Dose Selection
• Begin 002 Phase 2
• Continue with rest of studies (eg 006, 003 etc)
• MPS Program progress
• Continue great exposure in upcoming conferences (OARSI, Lysosomal in Sydney as just a couple of examples).
• Exciting discussions (ongoing) with FDA/EMA/TGA
• Progress in other indications already stated (Hearts/ARDS/AlphaViral etc)

There is a lot to do !! But eventually we will partner...it will be much easier to partner once a lot of the above is progressively and successfully checked off.

A new CEO will happen...whether it be from PAR finding one that's suitable or as a consequence of a Partnership.

Imagine we tick off the above bullet points with pristine data, the data is consistent and the safety profile is intact (you know what I'm gonna say here - my views)...and the FDA have meaningful and super discussions with us as they are so impressed with our data, efficacy and consistency...could this also not lend itself to potential candidates for such a role to come knocking on OUR door...could it not be that an eventual distributional partner have a world-wide call for candidates to help lead us to the exciting next stage of Global Revenue?

They (Big Pharma) would have their own list and certainly would be able to draw upon such incredible talent with precise ace experience to fit what we exactly need! Plus, at that stage, charged with a much more buoyant share price and cash on the books from such a lucrative deal, we could actually afford to pay them a decent package with shareholder's blessings.


As I often say, there are many ways this game can play out...it may not just be the long arduous timetable of trials and studies till 2026..then readout and then finally revenue thereafter. More to be said on this.







DYOR